Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Medtronic
Fuji
Moodys
US Department of Justice
Cerilliant
Federal Trade Commission
Queensland Health
Express Scripts
Teva

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Intermediates for anti-microbial quinolone carboxylic acids
Abstract:Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R.sup.1 is cyclopropyl which may have 1 to 3 substituents of alkyl and halogen; phenyl which may be substituted by 1 to 3 substituents of alkoxy, halogen and OH; alkyl which may be substituted by halogen, alkanoyloxy or OH; alkenyl; or thienyl, R.sup.2 is 5- to 9-membered saturated or unsaturated heterocyclic ring which may be substituted, R.sup.3 is alkyl, R is H or alkyl, and X is halogen, and pharmaceutically acceptable salts thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.
Inventor(s): Ueda; Hiraki (Michima, JP), Miyamoto; Hisashi (Tokushima, JP), Yamashita; Hiroshi (Tokushima, JP), Tone; Hitoshi (Itano, JP)
Assignee: Otsuka Pharmaceutical Company, Limited (Tokyo, JP)
Filing Date:Sep 03, 1997
Application Number:08/922,108
Claims:1. A compound of the formula: ##STR36## wherein R.sup.32 is a lower alkyl group; D is a carboxyl group; X.sup.2 is a halogen atom; X.sup.3 is a halogen atom; and X.sup.4 is a halogen atom.

2. A compound according to claim 1, wherein the compound is of the following formula: ##STR37## wherein X.sup.2, X.sup.3, X.sup.4, and R.sup.32 are as defined in claim 1.

3. A compound according to claim 1, which is a member selected from the group consisting of

2-methyl-3-fluoro-4,6-dibromobenzoic acid; and

2-methyl-3,4,6-trifluorobenzoic acid.

4. A compound according to claim 1, which is 2-methyl-3-fluoro-4,6-dibromobenzoic acid.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Novartis
Covington
Cipla
Argus Health
Daiichi Sankyo
Cerilliant
Citi
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot